Kedrion SpA, an international company that collects and fractionates blood plasma to produce and distribute plasma-derived therapeutic products, has named Val Romberg as its new CEO, it was reported on Friday.

Romberg has served for forty years at companies including West Pharmaceutical Services, Aventis Behring, ZLB Behring and CSL Behring. Most recently, he was the executive vice president of operations for CSL Behring.

Romberg said, said, 'I am very happy to join Kedrion, which produces and distributes essential therapeutic treatments for patients around the world. I am particularly pleased that this is coming as the company makes progress with the development of new therapeutic treatments for COVID-19 in collaboration with its research partner, the Irving Medical Center at the University of Colombia.'